Montagu Private Equity announces the sale of its share in Euromedic to Ares Life Sciences

2014.09.30

Montagu Private Equity LLP (“Montagu”), one of Europe’s longest established private equity firms, today announced the sale of its holding in Euromedic International (“Euromedic” or “the Company”), the largest pan-European medical services provider, to Ares Life Sciences (“Ares”), an investment partnership of Waypoint Capital and the current majority owner of the Company. Terms of the transaction were not disclosed. The transaction is expected to complete in 2014, subject to customary regulatory approvals.

Euromedic offers premium diagnostic imaging, cancer detection and cancer treatment services, with a focus on delivering prompt yet thorough diagnoses and high quality treatments by working only with state-of-the-art technology and experienced medical professionals. It operates 144 Diagnostic and Cancer Treatment Centers in 14 countries across Europe. The company employs over 3,000 professionals, of which more than 750 are medical doctors.

Michal Chalaczkiewicz, Director of Montagu, said:
“We are proud of our involvement with Euromedic over the last few years. Ares has a deep understanding of the company and we know that, together with management, they will continue to drive the business forward successfully. We would like to thank the Euromedic team for their great efforts.”

Dimitris Moulavasilis, CEO of Euromedic, said:
“We would like to thank Montagu for its support over the last six years. They have been excellent partners to Ares and management, leaving the company very well positioned to continue to grow. We look forward to building on our current, solid platform.”
 

About Montagu Private Equity

Montagu Private Equity is one of Europe’s longest established private equity firms. Founded in 1968, Montagu can look back on more than 40 years’ experience in investing in more than 400 transactions. Montagu has a strong track record of supporting portfolio companies, dedicating significant resources to management teams as well as providing additional capital expenditure to fund further growth. Montagu also has considerable expertise in helping businesses to accelerate their growth in their home markets as well as to internationalise and expand their customer base. This approach has led to real growth across Montagu’s portfolio. The firm has assets under management of €3.1 billion. Montagu invests in businesses that operate in stable markets across Europe with transaction values ranging from approximately €100 million to €1 billion.

www.montagu.com